News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
89,454 Results
Type
Article (4796)
Company Profile (7)
Press Release (84651)
Multimedia
Podcasts (13)
Webinars (2)
Section
Business (26549)
Career Advice (111)
Deals (4787)
Drug Delivery (15)
Drug Development (10444)
Employer Resources (8)
FDA (2595)
Job Trends (2301)
News (45810)
Policy (6385)
Tag
Academia (217)
Accelerated approval (1)
Allergies (17)
Alliances (6225)
ALS (32)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (17)
Approvals (2637)
Artificial intelligence (27)
Autoimmune disease (9)
Automation (2)
Bankruptcy (49)
Best Places to Work (1979)
Biosimilars (34)
Biotechnology (8)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (28)
Cancer (343)
Cardiovascular disease (24)
Career advice (92)
CAR-T (12)
CDC (7)
Cell therapy (33)
Cervical cancer (4)
Clinical research (8999)
Collaboration (108)
Compensation (20)
Complete response letters (5)
COVID-19 (528)
CRISPR (7)
C-suite (39)
Cystic fibrosis (11)
Data (355)
Depression (4)
Diabetes (37)
Diagnostics (553)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (24)
Drug pricing (25)
Drug shortages (2)
Duchenne muscular dystrophy (12)
Earnings (12967)
Editorial (6)
Employer branding (2)
Employer resources (8)
Events (9609)
Executive appointments (101)
FDA (2801)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (125)
Gene editing (12)
Generative AI (1)
Gene therapy (30)
GLP-1 (125)
Government (1659)
Grass and pollen (2)
Guidances (34)
Healthcare (2275)
HIV (15)
Huntington's disease (1)
Immunology and inflammation (38)
Immuno-oncology (1)
Indications (11)
Infectious disease (562)
Inflammatory bowel disease (32)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (16)
Interviews (16)
IPO (2125)
IRA (4)
Job creations (467)
Job search strategy (90)
Kidney cancer (3)
Labor market (2)
Layoffs (55)
Leadership (1)
Legal (835)
Liver cancer (8)
Longevity (1)
Lung cancer (55)
Lymphoma (26)
Machine learning (1)
Management (3)
Manufacturing (50)
MASH (2)
Medical device (1730)
Medtech (1730)
Mergers & acquisitions (2711)
Metabolic disorders (80)
Multiple sclerosis (26)
Neurodegenerative disease (18)
Neuropsychiatric disorders (4)
Neuroscience (234)
NextGen: Class of 2025 (521)
Non-profit (526)
Now hiring (1)
Obesity (38)
Opinion (31)
Ovarian cancer (14)
Pain (10)
Pancreatic cancer (7)
Parkinson's disease (9)
Partnered (1)
Patents (43)
Patient recruitment (21)
Peanut (7)
People (6862)
Pharmaceutical (2)
Pharmacy benefit managers (3)
Phase I (1907)
Phase II (3558)
Phase III (4173)
Pipeline (277)
Policy (23)
Postmarket research (450)
Preclinical (641)
Press Release (2)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (56)
Rare diseases (58)
Real estate (577)
Recruiting (5)
Regulatory (4335)
Reports (14)
Research institute (233)
Resumes & cover letters (14)
Rett syndrome (1)
RNA editing (1)
RSV (16)
Schizophrenia (6)
Series A (20)
Series B (17)
Service/supplier (3)
Sickle cell disease (5)
Special edition (5)
Spinal muscular atrophy (14)
Startups (361)
Stomach cancer (2)
Supply chain (5)
Tariffs (15)
The Weekly (13)
Vaccines (171)
Venture capital (8)
Weight loss (26)
Women's health (8)
Worklife (1)
Date
Today (7)
Last 7 days (47)
Last 30 days (235)
Last 365 days (3801)
2025 (1999)
2024 (4198)
2023 (4966)
2022 (10478)
2021 (10606)
2020 (9090)
2019 (6235)
2018 (5064)
2017 (4482)
2016 (3956)
2015 (4511)
2014 (3201)
2013 (2459)
2012 (2599)
2011 (2505)
2010 (2491)
Location
Africa (116)
Alabama (1)
Alaska (1)
Arizona (9)
Asia (3718)
Australia (861)
California (563)
Canada (1157)
China (89)
Colorado (8)
Connecticut (13)
Delaware (23)
Europe (11907)
Florida (128)
Georgia (33)
Idaho (5)
Illinois (38)
India (8)
Indiana (50)
Iowa (5)
Japan (30)
Kansas (4)
Kentucky (1)
Louisiana (1)
Maine (4)
Maryland (87)
Massachusetts (489)
Michigan (9)
Minnesota (18)
Missouri (13)
Nebraska (1)
Nevada (6)
New Hampshire (10)
New Jersey (315)
New York (252)
North Carolina (59)
North Dakota (1)
Northern California (299)
Ohio (15)
Oregon (5)
Pennsylvania (156)
South America (160)
South Carolina (1)
Southern California (202)
Tennessee (3)
Texas (99)
United States (2419)
Utah (10)
Virginia (6)
Washington D.C. (1)
Washington State (42)
Wisconsin (1)
89,454 Results for "sanofi aventis canada".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
2024 Sanofi Biogenius Canada Grants open for applications
sanofi-aventis Canada inc. is pleased to announce that applications for the 2024 Sanofi Biogenius Canada Grants are now open.
March 19, 2024
·
4 min read
Collaboration
Sanofi, Gilead Deepen Protein Degrader Pipelines in Separate Deals With Kymera
Gilead is betting up to $750 million on Kymera’s anti-CDK2 molecular glue for solid tumors, while Sanofi elected to move forward with another protein degrader from the biotech, designed to target immune-mediated diseases.
June 25, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
In latest AI Play, Sanofi Bets $630M+ for Formation Bio’s JAK/SYK Blocker
The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.
June 24, 2025
·
2 min read
·
Tristan Manalac
RSV
Merck Wins FDA Nod for RSV Antibody, Tees Up Challenge to Sanofi, AstraZeneca
Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.
June 10, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio
Blueprint has a next-generation systemic mastocytosis treatment, called elenestinib, that Sanofi CEO Paul Hudson told analysts provides an “opportunity to grow through the ‘30s.”
June 2, 2025
·
3 min read
·
Nick Paul Taylor
Manufacturing
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment
Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.
May 15, 2025
·
2 min read
·
Tristan Manalac
Clinical research
Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II
Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.
April 16, 2025
·
2 min read
·
Tristan Manalac
Legal
BMS, Sanofi Settle Plavix Suit With Hawaii for $700M
The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform patients in the state that the drug is likely to be less effective for them.
May 12, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Action Alert: Regeneron, Sanofi and Abeona
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
April 14, 2025
·
3 min read
·
Tristan Manalac
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
Canada’s health agency says it has been “taking all necessary action safeguard the drug supply and ensure Canadians have access to the prescription drugs they need.”
May 22, 2025
·
2 min read
·
Annalee Armstrong
1 of 8,946
Next
